Effect of DMMET-01 on Insulin Sensitivity in Naive Type 2 Diabetes Patients (CLAMP)

NCT00940797 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

20

Enrollment

INDUSTRY

Sponsor class

Conditions

Diabetes Type 2

Interventions

DRUG: DMMET-01
DRUG: Placebo

Sponsor

Laboratorios Silanes S.A. de C.V.